IPSEN (IPN.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:IPN - FR0010259150 - Common Stock
119.4 EUR
-0.9 (-0.75%)
Taking everything into account, IPN scores 6 out of 10 in our fundamental rating. IPN was compared to 54 industry peers in the Pharmaceuticals industry. IPN has an excellent financial health rating, but there are some minor concerns on its profitability. IPN may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, IPN could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
In the past year IPN was profitable.
IPN had a positive operating cash flow in the past year.
In the past 5 years IPN has always been profitable.
In the past 5 years IPN always reported a positive cash flow from operatings.
1.2 Ratios
IPN has a Return On Assets (6.56%) which is in line with its industry peers.
IPN's Return On Equity of 10.59% is in line compared to the rest of the industry. IPN outperforms 55.56% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.88%, IPN is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
IPN had an Average Return On Invested Capital over the past 3 years of 12.97%. This is in line with the industry average of 13.79%.
The 3 year average ROIC (12.97%) for IPN is below the current ROIC(14.88%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROIC | 14.88% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
1.3 Margins
Looking at the Profit Margin, with a value of 11.91%, IPN is in line with its industry, outperforming 50.00% of the companies in the same industry.
IPN's Profit Margin has declined in the last couple of years.
The Operating Margin of IPN (26.01%) is better than 64.81% of its industry peers.
IPN's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 83.32%, IPN belongs to the best of the industry, outperforming 90.74% of the companies in the same industry.
IPN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% |
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IPN is creating value.
The number of shares outstanding for IPN has been increased compared to 1 year ago.
The number of shares outstanding for IPN remains at a similar level compared to 5 years ago.
Compared to 1 year ago, IPN has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.45 indicates that IPN is not in any danger for bankruptcy at the moment.
The Altman-Z score of IPN (4.45) is better than 62.96% of its industry peers.
IPN has a debt to FCF ratio of 1.69. This is a very positive value and a sign of high solvency as it would only need 1.69 years to pay back of all of its debts.
IPN has a Debt to FCF ratio of 1.69. This is amongst the best in the industry. IPN outperforms 88.89% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that IPN is not too dependend on debt financing.
IPN's Debt to Equity ratio of 0.20 is fine compared to the rest of the industry. IPN outperforms 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Altman-Z | 4.45 |
ROIC/WACC1.9
WACC7.84%
2.3 Liquidity
A Current Ratio of 1.98 indicates that IPN should not have too much problems paying its short term obligations.
The Current ratio of IPN (1.98) is better than 72.22% of its industry peers.
A Quick Ratio of 1.80 indicates that IPN should not have too much problems paying its short term obligations.
IPN has a Quick ratio of 1.80. This is amongst the best in the industry. IPN outperforms 81.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.24% over the past year.
Measured over the past years, IPN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.79% on average per year.
IPN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.45%.
Measured over the past years, IPN shows a small growth in Revenue. The Revenue has been growing by 5.83% on average per year.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
3.2 Future
The Earnings Per Share is expected to grow by 5.58% on average over the next years.
IPN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.58% yearly.
EPS Next Y9.37%
EPS Next 2Y3.92%
EPS Next 3Y4.54%
EPS Next 5Y5.58%
Revenue Next Year8.6%
Revenue Next 2Y6.18%
Revenue Next 3Y6.04%
Revenue Next 5Y4.58%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 11.63, the valuation of IPN can be described as very reasonable.
Based on the Price/Earnings ratio, IPN is valued a bit cheaper than the industry average as 77.78% of the companies are valued more expensively.
IPN is valuated cheaply when we compare the Price/Earnings ratio to 26.61, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 10.76, which indicates a very decent valuation of IPN.
Based on the Price/Forward Earnings ratio, IPN is valued a bit cheaper than the industry average as 77.78% of the companies are valued more expensively.
IPN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.01.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.63 | ||
| Fwd PE | 10.76 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IPN indicates a rather cheap valuation: IPN is cheaper than 96.30% of the companies listed in the same industry.
IPN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IPN is cheaper than 68.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.4 | ||
| EV/EBITDA | 5.67 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
IPN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.24
PEG (5Y)1.32
EPS Next 2Y3.92%
EPS Next 3Y4.54%
5. Dividend
5.1 Amount
IPN has a Yearly Dividend Yield of 1.17%. Purely for dividend investing, there may be better candidates out there.
IPN's Dividend Yield is comparable with the industry average which is at 1.85.
Compared to the average S&P500 Dividend Yield of 1.87, IPN is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.17% |
5.2 History
The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
25.90% of the earnings are spent on dividend by IPN. This is a low number and sustainable payout ratio.
The dividend of IPN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.9%
EPS Next 2Y3.92%
EPS Next 3Y4.54%
EPA:IPN (12/22/2025, 7:00:00 PM)
119.4
-0.9 (-0.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners15.21%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap10.01B
Revenue(TTM)3.76B
Net Income(TTM)447.90M
Analysts68.89
Price Target131.89 (10.46%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.17% |
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP25.9%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.12%
PT rev (3m)2.63%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.5%
EPS NY rev (3m)7.88%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)1.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.63 | ||
| Fwd PE | 10.76 | ||
| P/S | 2.66 | ||
| P/FCF | 19.4 | ||
| P/OCF | 11.15 | ||
| P/B | 2.37 | ||
| P/tB | 7.5 | ||
| EV/EBITDA | 5.67 |
EPS(TTM)10.27
EY8.6%
EPS(NY)11.09
Fwd EY9.29%
FCF(TTM)6.15
FCFY5.15%
OCF(TTM)10.71
OCFY8.97%
SpS44.86
BVpS50.46
TBVpS15.93
PEG (NY)1.24
PEG (5Y)1.32
Graham Number107.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROCE | 18.07% | ||
| ROIC | 14.88% | ||
| ROICexc | 20.46% | ||
| ROICexgc | 77.25% | ||
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% | ||
| FCFM | 13.72% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
ROICexc(3y)20.33%
ROICexc(5y)25.52%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.75%
ROCE(5y)18.64%
ROICexgc growth 3Y-59.92%
ROICexgc growth 5Y-22.83%
ROICexc growth 3Y-29.05%
ROICexc growth 5Y-11.89%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Debt/EBITDA | 0.5 | ||
| Cap/Depr | 55.54% | ||
| Cap/Sales | 10.15% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 53.9% | ||
| Profit Quality | 115.14% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 4.45 |
F-Score7
WACC7.84%
ROIC/WACC1.9
Cap/Depr(3y)131.36%
Cap/Depr(5y)124.73%
Cap/Sales(3y)11.81%
Cap/Sales(5y)11.18%
Profit Quality(3y)85.87%
Profit Quality(5y)89.99%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
EPS Next Y9.37%
EPS Next 2Y3.92%
EPS Next 3Y4.54%
EPS Next 5Y5.58%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
Revenue Next Year8.6%
Revenue Next 2Y6.18%
Revenue Next 3Y6.04%
Revenue Next 5Y4.58%
EBIT growth 1Y66.72%
EBIT growth 3Y-6.06%
EBIT growth 5Y1.3%
EBIT Next Year41.46%
EBIT Next 3Y13.73%
EBIT Next 5Y7.89%
FCF growth 1Y-33.64%
FCF growth 3Y-35.67%
FCF growth 5Y-17.46%
OCF growth 1Y-8.92%
OCF growth 3Y-0.07%
OCF growth 5Y7.84%
IPSEN / IPN.PA FAQ
What is the fundamental rating for IPN stock?
ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.
Can you provide the valuation status for IPSEN?
ChartMill assigns a valuation rating of 7 / 10 to IPSEN (IPN.PA). This can be considered as Undervalued.
Can you provide the profitability details for IPSEN?
IPSEN (IPN.PA) has a profitability rating of 6 / 10.
What is the earnings growth outlook for IPSEN?
The Earnings per Share (EPS) of IPSEN (IPN.PA) is expected to grow by 9.37% in the next year.
Can you provide the dividend sustainability for IPN stock?
The dividend rating of IPSEN (IPN.PA) is 4 / 10 and the dividend payout ratio is 25.9%.